20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks
PRAX-628-321
Phase 3 small_molecule active
Quick answer
20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks for Focal Seizure is a Phase 3 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Focal Seizure
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active